JDRF Announces New Outreach Kit to Support Adults Newly Diagnosed with Type 1
NEW YORK, April 15, 2013
-- In collaboration with its partners—Bayer Healthcare, Medtronic, and Novo
Nordisk—JDRF's Adult Type 1 Pak is a sling-style bag with resources for
newly-diagnosed adults --
NEW YORK, April 15, 2013 /PRNewswire-USNewswire/ --JDRF announced today that
it has created a new resource for adults newly diagnosed with type 1 diabetes
(T1D). The Adult Type 1 Pak is a sling-style bag that will include important
resources and information to educate, support, and inspire adults newly
diagnosed with T1D, age 16 and above. In collaboration with JDRF's generous
sponsors—Bayer Healthcare, Medtronic, and Novo Nordisk—the kit is now
available through local JDRF chapters, and is free of charge.
(Photo: http://photos.prnewswire.com/prnh/20130415/DC94365 )
The Adult Type 1 Pak was created as a part of an effort to ensure that all
individuals newly diagnosed with T1D receive the information and support
necessary to adjust to life with the disease.JDRF has found the Bag of Hope
to be extremely beneficial to families of newly-diagnosed children with T1D,
and is hopeful that the Adult Type 1 Pak will be just as valuable to
newly-diagnosed adults. Each year in the United States alone, more than 15,000
children and 15,000 adults are diagnosed with T1D, and JDRF continues to work
to expand its efforts to better support people of all ages, and at all stages
of life with the disease.
"JDRF is wholeheartedly committed to all people with type 1 diabetes, and
adults make up 85 percent of that population," said Jeffrey Brewer, president
and CEO of JDRF. "Adults who are newly diagnosed face challenges that are very
different from children who are newly diagnosed, and we are proud to be able
to offer this resource to help them take charge of their lives in the midst of
such a huge transition. Most importantly, we want these adults to know that
they have a network of support through JDRF and that amazing progress is being
made in type 1 diabetes research. We're grateful to Bayer Healthcare,
Medtronic, and Novo Nordisk for their support of the Adult Type 1 Pak."
Newly-diagnosed adults with T1D can contact their local JDRF chapters for the
Adult Type 1 Pak, and for more information on ways to get involved with JDRF
and the T1D community.
JDRF is the leading global organization funding type 1 diabetes (T1D)
research. JDRF's goal is to progressively remove the impact of T1D from
people's lives until we achieve a world without T1D. JDRF collaborates with a
wide spectrum of partners and is the only organization with the scientific
resources, regulatory influence, and a working plan to better treat, prevent,
and eventually cure T1D.
As the largest charitable supporter of T1D research, JDRF is currently
sponsoring $530 million in scientific research in 17 countries. In 2012 alone,
JDRF provided more than $110 million to T1D research. More than 80 percent of
JDRF's expenditures directly support research and research-related education.
In 2012 Forbes magazine named JDRF one of its five All-Star charities, citing
the organization's efficiency and effectiveness.
For more information, please visitjdrf.org.
Press spacebar to pause and continue. Press esc to stop.